Supporters of embryonic stem cell research received a pair of good omens today.
At a Senate hearing, National Institutes of Health director Elias Zerhouni criticized Bush's stem cell policy.
"I think it's important for us not to function with one hand tied behind our back here," Zerhouni said. "To sideline NIH in an issue of such importance is shortsighted."
...
"It's very clear these cell lines will not be sufficient to do all the research we need to do," Zerhouni said in response to a question from Sen. Tom Harkin, D-Iowa, chair of the appropriations subcommittee with jurisdiction over the Department of Health and Human Services.
"It is clear today that American science will be better served and the nation will be better served if we let our scientists have access to more cell lines," he added.
This statement will definitely be cited when the Stem Cell Research Enhancement Act receives a Senate vote.
In other news, Arlen Specter announced that he will run for a sixth term as Senator. Specter has been one of the strongest advocates for expanding embryonic stem cell research in Congress, so having him in through 2014 is a huge win for proponents.
Analysis: NIH Head Backs Stem Cell Use [UPI]
Specter's Early Announcement Sends a 'Warning' [The Hill]
